ArticleCancer discovery2023
The Promise and Limitations of Neoadjuvant Immune-Checkpoint Blockade in Resectable Non-Small Cell Lung Cancer.
Alissa J Cooper et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it